Altre lingue BioNTech SE Sao Paulo

Azioni

B1NT34

BRB1NTBDR005

Mercato chiuso - Sao Paulo Altri mercati azionari 21:49:52 31/05/2024			Variaz. 5gg	Var. 1 gen.
33,03 ^BRL	+10,10%		+5,87%	+3,87%

31/05	I titoli azionari europei scambiati negli Stati Uniti come ricevute americane di deposito aumentano venerdì, ma sono destinati a chiudere la settimana in ribasso	MT
29/05	BioNTech, CEPI ampliano la partnership per l'ecosistema di vaccini mRNA in Africa	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

European Equities Traded in US as American Depositary Receipts Rise Friday, Poised to End Week Lower	31/05
BioNTech, CEPI Expand Partnership for mRNA Vaccine Ecosystem in Africa	29/05
BioNTech gets $145 mln funding for African vaccine plants	29/05
BioNTech wins up to $145 mln in CEPI support for African mRNA vaccine plants	29/05
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Tuesday Trading	28/05
BioNTech Collaborating with MediLink to Develop More Potential Antibody-Drug Conjugate, Immunotherapy Treatments	28/05
European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	24/05
BIONTECH : Deutsche Bank remains Neutral	24/05
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading	22/05
Medigene, BioNTech Extend Cancer Immunotherapy Partnership	21/05
Medigene AG's Global Research & Collaboration Agreement with BioNTech SE to Extend Beyond Initial Announced Term	21/05
Sector Update: Health Care Stocks Mixed Late Afternoon	17/05
Sector Update: Health Care Stocks Softer Friday Afternoon	17/05
Sector Update: Health Care	17/05
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech	17/05
Moderna Wins European Patent Ruling in Covid-19 Vaccine Dispute With Pfizer, BioNTech	17/05
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	17/05
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot, FT reports	17/05
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	17/05
Autolus Therapeutics' Q1 Loss Widens, Licensing Revenue Rises	17/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

In prima pagina

BIONTECH : Una mancanza è una mancanza

21 marzo 2024 alle 14:27

BioNTech SE: valutazione in crisi

21 marzo 2024 alle 11:56